It looks like Apple’s (AAPL) big product-launch event lived up to the hype. Many analysts expect iPhone users to ditch their current phones and buy one of Apple’s new models. High demand for the iPhone X, iPhone 8 and iPhone 8 Plus …
Old Versus New Paradigm in Biotechnology Collaborations In addition ... However, MD Becker Partners receives no compensation to write about any specific stock, sector or theme, and will not hold positions or otherwise trade or effect …
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. Its drug candidates include glembatumumab vedotin, …
NEW YORK, Oct. 18, 2016 /CNW/ - TradersNewsSource.com Biotechnology Market News: Two small-cap biotech …
Yahoo is now part of ‘Oath’ and a member of the Verizon family of companies. As of 15 September 2017, we plan to share some user information within our new family. Learn more
Celldex Therapeutics (NASDAQ:CLDX) traded in a range yesterday that spanned from a low of $3.20 to a high of …
*Close price adjusted for splits.**Adjusted close price adjusted for both dividends and splits. Loading more data...